Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy.

about

Transthyretin familial amyloid polyneuropathy: an update.Axon reflex-mediated vasodilation is reduced in proportion to disease severity in TTR-FAP

P2860

Q47562649-C5DCB040-C8F7-44B7-8C86-350E53550B7C Q58803264-3EF729F4-E7B1-40A7-82E0-CC461EAE6D26

P2860

Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy.

Item

http://www.wikidata.org/entity/Q40166313

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy.

@en

type

Item

label

Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy.

@en

prefLabel

Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy.

@en

P1476

Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy

@en

P2093

Blessan Sebastian

http://www.w3.org/2001/XMLSchema#string

Gigi J Ebenezer

http://www.w3.org/2001/XMLSchema#string

Kelly Byrnes

http://www.w3.org/2001/XMLSchema#string

Kelly Cunningham

http://www.w3.org/2001/XMLSchema#string

Michael Polydefkis

http://www.w3.org/2001/XMLSchema#string

Noel D Carter

http://www.w3.org/2001/XMLSchema#string

Shaun Truelove

http://www.w3.org/2001/XMLSchema#string

Ying Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates

First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripher

Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy

NIS-LL: the primary measurement scale for clinical trial endpoints in diabetic peripheral neuropathy.

Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial

Quantification of sudomotor innervation: a comparison of three methods.

In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography.

Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosis

Early detection of nerve injury in transthyretin-related familial amyloid polyneuropathy.

P304

44-56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.24972

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Daniel P Judge

P577

2017-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28598015

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy.

about

P2860

P2860

Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921